Hidehiro Nishi

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori et al. · Hepatology · 2006 · 361 citations · Full text

Medicine, Hematology, Immunology +13

Prevalence of hepatitis B or C virus infections in patients with non‐Hodgkin's lymphoma

Masami Kuniyoshi, Makoto Nakamuta, Hironori Sakai et al. · Journal of Gastroenterology and Hepatology · 2001 · 111 citations

Medicine, Hematology, Pathology +13

Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma

K Noguchi, Munechika Enjoji, Makoto Nakamuta et al. · Cancer Letters · 2001 · 52 citations

Life Sciences, Molecular Biology, Oncology +14

The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E‐cadherin, alpha‐catenin and beta‐catenin

Yoshiki Asayama, Ken‐ichi Taguchi, Shinichi Aishima et al. · Liver International · 2002 · 40 citations

Medicine, Oncology, Pathology +17

The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract

Munechika Enjoji, Manabu Nakashima, Hidehiro Nishi et al. · Journal of Hepatology · 2002 · 35 citations

Medicine, Immunology, Oncology +13